Clomiphene misuse and risk of severe cardiovascular events
Eur J Clin Pharmacol
.
2020 Jun;76(6):901-902.
doi: 10.1007/s00228-020-02858-4.
Epub 2020 Mar 17.
Authors
Céline Eiden
1
,
Véronique Pinzani
2
,
Marion Laureau
3
,
Nicolas Chapet
4
,
Juline Beringer
3
,
François Roubille
4
5
,
Mustapha Sebbane
3
,
Hélène Peyrière
2
Affiliations
1
Department of Medical Pharmacology and Toxicology, Montpellier University Hospital, 34295, Montpellier Cedex 5, France. c-eiden@chu-montpellier.fr.
2
Department of Medical Pharmacology and Toxicology, Montpellier University Hospital, 34295, Montpellier Cedex 5, France.
3
Department of Emergency, Montpellier University Hospital, 34295, Montpellier Cedex 5, France.
4
Department of Cardiology, Montpellier University Hospital, 34295, Montpellier Cedex 5, France.
5
PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, 34295, Montpellier Cedex 5, France.
PMID:
32185402
DOI:
10.1007/s00228-020-02858-4
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Adult
Cardiovascular Diseases / etiology*
Clomiphene / adverse effects*
Humans
Male
Substances
Clomiphene